Minimally Invasive Hepatobiliary and Colorectal Surgery: Precision, Safety, and Faster Recovery

The Evolution of Minimally Invasive Surgery

The past three decades have witnessed a remarkable transformation in general surgery, driven by the adoption of minimally invasive techniques that offer patients smaller incisions, reduced postoperative pain, shorter hospital stays, and faster return to normal activities. What began with laparoscopic cholecystectomy in the late 1980s has expanded to encompass some of the most complex operations in abdominal surgery, including major liver resections, pancreatic procedures, and advanced colorectal cancer surgery.

At Hong Kong Sanatorium & Hospital, our surgical team has been at the forefront of this evolution, performing over 3,000 minimally invasive procedures across the full spectrum of hepatobiliary and colorectal pathology. This article examines the current state of the art in laparoscopic and robotic surgery for these conditions, with a focus on the evidence supporting their adoption and the specific advantages they offer to international patients seeking treatment in Hong Kong.

Laparoscopic Liver Resection: From Innovation to Standard Practice

Laparoscopic liver resection (LLR) has evolved from an experimental technique to an established approach for both benign and malignant hepatic conditions. The 2018 Southampton International Consensus Guidelines endorsed laparoscopic approaches for minor liver resections and left lateral sectionectomies, while the 2023 Yokohama update extended recommendations to include major hepatectomies in experienced centres.

Contemporary evidence demonstrates that laparoscopic liver resection offers significant advantages over open surgery: a 2025 systematic review published in Hepatobiliary Surgery and Nutrition confirmed that LLR is associated with reduced intraoperative blood loss (mean reduction of 200–300 mL), shorter hospital stays (median 4 days vs 7 days for open surgery), lower rates of wound complications, and equivalent oncological outcomes for both hepatocellular carcinoma and colorectal liver metastases.

For patients with hepatocellular carcinoma — a condition particularly prevalent in the Asia-Pacific region — laparoscopic resection offers the additional advantage of reduced adhesion formation, which is critically important for patients who may require future liver transplantation or repeat resection. Our centre has performed over 500 laparoscopic liver procedures, including complex anatomical resections guided by intraoperative ultrasound and indocyanine green (ICG) fluorescence imaging.

Robotic Hepatobiliary Surgery: The Next Generation

Robotic surgical systems, particularly the da Vinci platform, are increasingly complementing laparoscopic approaches in hepatobiliary surgery. The articulated instruments provide seven degrees of freedom, tremor filtration, and three-dimensional high-definition visualisation — advantages that are particularly valuable when operating near critical vascular structures such as the hepatic veins and portal pedicles.

A 2025 review in Current Hepatology Reports highlighted that robotic liver resection is associated with comparable operative times and oncological outcomes to laparoscopic approaches, with potential advantages in complex anatomical resections requiring precise hilar dissection. The integration of artificial intelligence into preoperative planning — using 3D reconstruction of CT and MRI data to create patient-specific virtual liver models — is further enhancing surgical precision and safety.

For biliary surgery, the robotic platform has expanded the scope of minimally invasive approaches to include complex bile duct reconstructions and Whipple procedures. A 2025 retrospective cohort study demonstrated that robot-assisted bile ductoplasty achieved comparable outcomes to open surgery with significantly reduced recovery times, suggesting that even the most technically demanding hepatobiliary operations can be performed through minimally invasive approaches.

Colorectal Cancer Surgery: The Robotic Revolution

Colorectal cancer is the second most common cancer in Hong Kong and a leading cause of cancer-related mortality in the GCC region. Minimally invasive surgery has become the standard of care for most colorectal cancers, with robust evidence from randomised controlled trials (COLOR II, ACOSOG Z6051, ALaCaRT) demonstrating equivalent oncological outcomes to open surgery with superior short-term recovery.

The adoption of robotic surgery has been particularly transformative for rectal cancer, where the confined pelvic anatomy makes conventional laparoscopic dissection technically challenging. A landmark 2025 study published in Diseases of the Colon & Rectum analysed national trends and found that the rise in minimally invasive colorectal surgery is primarily driven by robotic adoption, with robotic cases demonstrating lower conversion rates to open surgery (6.3% vs 12.6% for laparoscopic approaches) and comparable complication rates.

At our centre, we employ the robotic platform for total mesorectal excision (TME) in rectal cancer, achieving circumferential resection margin positivity rates below 3% — well within international benchmarks. The enhanced visualisation and instrument articulation are particularly valuable for ultra-low anterior resections, where preserving the anal sphincter complex is critical for maintaining quality of life.

Single-Port and Natural Orifice Surgery

The latest evolution in minimally invasive surgery involves single-port approaches, where the entire operation is performed through a single small incision, typically hidden within the umbilicus. Single-port laparoscopic cholecystectomy has become routine at our centre, offering virtually scarless surgery with equivalent safety to conventional four-port techniques.

For colorectal surgery, transanal total mesorectal excision (TaTME) represents a paradigm shift, approaching the rectal tumour from below through the natural orifice of the anus. This technique is particularly advantageous for obese male patients with narrow pelves, where conventional top-down approaches may be technically limited. Combined with robotic assistance from above, this hybrid approach achieves excellent oncological and functional outcomes.

Enhanced Recovery After Surgery (ERAS)

Minimally invasive techniques are most effective when integrated within comprehensive Enhanced Recovery After Surgery (ERAS) protocols. Our multidisciplinary ERAS programme encompasses preoperative optimisation (nutritional support, prehabilitation exercise), intraoperative strategies (goal-directed fluid therapy, multimodal analgesia), and structured postoperative pathways (early mobilisation, early oral feeding).

The combination of minimally invasive surgery and ERAS has dramatically reduced hospital stays: patients undergoing laparoscopic right hemicolectomy are typically discharged within 3–4 days, while those having robotic low anterior resection return home within 5–6 days. For liver resections, the median hospital stay has decreased from 10 days (open surgery without ERAS) to 4–5 days (laparoscopic with ERAS).

Why Hong Kong for Minimally Invasive Surgery

Hong Kong's position as a centre of excellence for minimally invasive surgery is built on several pillars: surgeons trained at world-leading institutions with fellowship experience in advanced laparoscopic and robotic techniques; access to the latest robotic platforms and intraoperative imaging technology; rigorous quality assurance programmes with outcomes benchmarked against international standards; and a healthcare system that combines the efficiency of private practice with the academic rigour of university-affiliated hospitals.

For GCC patients, the practical advantages are equally compelling. The visa-free entry policy eliminates administrative delays, allowing treatment to begin within days of initial consultation. The city's world-class hotel infrastructure, halal dining options, and Arabic-speaking medical coordinators ensure that the treatment experience extends beyond the operating theatre to encompass comprehensive, culturally sensitive care throughout the recovery period.